¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº-TB

Home
Menu

World TB Day 2018

On 24 March, the world commemorates the day in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis. We take this opportunity each year to highlight contemporary research innovation and future challenges in a one-day symposium co-organised by LSHTM and ¹û¶³Ó°Ôº.

For the 2018 event, our audience - in person at the John Snow Lecture Theatre and the hundreds who watched online - heard about a wide variety of studies as well as an impassioned call to action from Nick Herbert MP, who is a key player in preparations for September's UN high-level meeting on TB.Ìý Another treat was the launch of Public Health England's LTBI public awareness film.

We were also delighted to link up with our friends at UCSF for our very first "super-symposium".Ìý UCSF streamed our final session in their auditorium before we handed over to them and streamed their talks from while our delegates enjoyed a post-symposium drink.Ìý For more about the UCSF event, .

We are still accepting your papers for a special collection that we've been putting together with F1000 Research, so please don't hesitate to send those in.Ìý And if you have any feedback on the 2018 symposium and thoughts for 2019's event, please contact us at tb@ucl.ac.uk.

Recordings of the talks are now available here:

Full programme

9.00-9.35amRegistration and coffee
9.35-9.50amWelcome address
(LSHTM) and Prof Michael Arthur (¹û¶³Ó°Ôº)
9.50-10.00amGlobal TB Advocacy in 2018
(APPG on Global TB, and Global TB Caucus)
10.00-11.00amSession 1: Drug resistant TB - what is it, where is it and how is it spread?
Prof Tim McHugh (¹û¶³Ó°Ôº, chair)
(¹û¶³Ó°Ôº)
Global transmission of drug resistant Mycobacterium tuberculosis L4 strains
(¹û¶³Ó°Ôº)
Non-tuberculous mycobacteria (NTM) and antibiotic resistance
(¹û¶³Ó°Ôº)
Isoniazid monoresistant tuberculosis: Bad Medicine?
(LSHTM)
Transmission of drug-resistant TB
11.00-11.30amCoffee and networking breakÌý
11.30²¹³¾-12.30±è³¾ÌýSession 2: What should we do about drug-resistant TB?
(LSHTM, chair)
(MSF)
TB-Practecal trial updates
(Queen Margaret University)
Putting systems in place to address drug-resistant TB: the role of 'hardware' and 'software'
(¹û¶³Ó°Ôº)
Pharmacodynamic drug-drug interactions in antibiotic treatment combinations
(¹û¶³Ó°Ôº)
STREAM preliminary results: what do they tell us?
12.30-1.30pmLunch breakÌý
1.30-1.45pmPublic Health England: raising public awareness of LTBI
(PHE), Dr Matthew Burman (QMUL), Lee Ellis, Mark Nunn ()
1.45-3.00±è³¾ÌýSession 3: Debate - Do we need host-directed therapies if we have a universal drug regimen?
(LSHTM, chair)
Ìý(University of Emory Medical School)
Ìý(University of St Andrews)
3.00-3.30±è³¾ÌýCoffee and networking breakÌý
3.30-4.30±è³¾ÌýSession 4:ÌýNovel approaches to identify new therapies
(LSHTM, chair)
(¹û¶³Ó°Ôº)
Calibrating a balanced immune response in tuberculosis
(Francis Crick Institute)
How to make "resistance-proof" antibiotics?
(Oxford University)
Progress and challenges in TB vaccine development
(University of Southampton)
Investigation of TB in a bioengineered human granuloma model
4.30-4.45±è³¾ÌýSummary, thanks and

Ìý